Virus-specific T cells for malignancies - then, now and where to?
Sandhya SharmaWingchi K LeungHelen E Heslop
Published in: Current stem cell reports (2020)
This review focuses on data from clinical trials evaluating VSTs directed against three viruses (EBV, HPV and MCPyV), as well as recent preclinical and clinical advances, and potential future directions.